Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: ALX Oncology Holdings Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ALX Oncology Holdings Inc. June 12, 202479.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | ALX Oncology Holdings Inc. | Open-market sale | −2,230 | $1.93 | $4,304 |
| Mar 19, 2026 | ALX Oncology Holdings Inc. | Open-market sale | −12,311 | $2.17 | $26,715 |
| Feb 17, 2026 | ALX Oncology Holdings Inc. | Shares withheld for tax | −2,201 | $2.27 | $4,996 |
| Sep 17, 2025 | ALX Oncology Holdings Inc. | Open-market purchase | +71,163 | $1.08 | $76,856 |
| Sep 16, 2025 | ALX Oncology Holdings Inc. | Open-market purchase | +21,070 | $1.07 | $22,545 |
| Aug 15, 2025 | ALX Oncology Holdings Inc. | Open-market sale | −2,382 | $0.64 | $1,524 |
| Mar 14, 2025 | ALX Oncology Holdings Inc. | Grant or award | +42,000 | — | — |
| Feb 19, 2025 | ALX Oncology Holdings Inc. | Open-market sale | −2,159 | $1.15 | $2,483 |
| Aug 14, 2024 | ALX Oncology Holdings Inc. | Shares withheld for tax | −2,191 | $2.58 | $5,653 |
| Mar 14, 2024 | ALX Oncology Holdings Inc. | Open-market purchase | +4,400 | $11.31 | $49,764 |
| Feb 14, 2024 | ALX Oncology Holdings Inc. | Grant or award | +60,000 | — | — |
Questions about Jason Lettmann
What boards is Jason Lettmann on?
Jason Lettmann sits on the board of ALX Oncology Holdings Inc.
What company is Jason Lettmann the CEO of?
Jason Lettmann is Chief Executive Officer of ALX Oncology Holdings Inc.
How long has Jason Lettmann served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.